Proliferative index in breast carcinoma determined <i>in situ</i> by Ki67 immunostaining and its relationship to clinical and pathological variables
Abstract Sixty cases of primary breast carcinoma have been studied using a monoclonal antibody, Ki67, which recognizes an antigen expressed by cells in G1, S, G2, and M phases o...